Pfizer gets WHO’s approval
Despite less appearance in India, Pfizer and BioNTech is dominating the world. News agency AFP reports WHO approved the vaccine developed by Pfizer and BioNTech for emergency use on Thursday, paving the way for import and distribution of millions of does around the world.
According to US-based drug manufacturer Pfizer and German-based BioNTech, their vaccine efficiency is 95 percent. On 2 December last year, the UK became the first country to approve Pfizer-BioNTech vaccine and began immunising on December 8. Later, USA, Canada, Bahrain, Saudi Arabia and several European countries followed the UK.
WHO said, Pfizer-BioNTech vaccine is the first to get its clearance a year after coronavirus broke out in China and it’s a positive step to ensure global accessibility of Covid-19 vaccine. Besides, Pfizer-BioNTech vaccine is safe and secure in line with its rules and regulations on vaccination.
However, Pfizer-BioNTech vaccine needs sub-zero temperature. It needs to be preserved at minus 70 degrees Celsius. On the other hand, the Oxford vaccine is relatively less costly and easy to preserve. It can be kept in a normal freezer.
India is set to become the first country to run a trial vaccination programme in South Asia, beginning on Saturday. Health Minister Harsh Vardhan said preparation has been taken similar to that of a national election. Their main goal is to avoid any mistake when the actual vaccination begins.
